Exploiting the activity of VP22 to enhance the delivery of antigens encoded by DNA vaccine plasmids by Roopchand, Vidia et al.
BioMed  Central
Page 1 of 1
(page number not for citation purposes)
Retrovirology
Open Access Oral presentation
Exploiting the activity of VP22 to enhance the delivery of antigens 
encoded by DNA vaccine plasmids
Vidia Roopchand*, Dorys Garcia-Hand, Kangjian Wu, Emily Binder and 
Maninder Sidhu
Address: Vaccine Discovery, Wyeth Vaccines Research, Pearl River, New York, 10965, USA
* Corresponding author    
Herpes simplex virus type 1 (HSV-1) virion protein VP22
possesses the remarkable ability to engage in intercellular
trafficking where VP22 is exported from the cell in which
it is synthesized and penetrates surrounding cells. Previ-
ous data indicates that it is useful for vaccine development
by improving the delivery of immunogenic proteins. We
constructed plasmids encoding VP22 fused to either influ-
enza virus NP or HIV gag and tested whether such heterol-
ogous fusion proteins were capable of intercellular
trafficking or enhanced antigen delivery, both in vitro and
in vivo. To analyze intercellular trafficking, culture media
from transfected monolayers were added subsequently to
untransfected cells and uptake of the fusion protein was
examined by immunofluorescence. We found that the
VP22-NP fusion protein was localized in the cytoplasm of
transfected cells and was efficiently transported to recipi-
ent cells. Results from similar assays conducted with
VP22-gag fusion protein will be presented. In addition,
expression and immunogenicity of plasmids encoding the
VP22-NP and VP22-gag fusions following inoculation in
Balb/C mice will be presented.
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